文献速递类风湿关节炎

关节痛患者进展为类风湿关节炎的预测:现状综述

Which patients presenting with arthralgia eventually develop rheumatoid arthritis? The current state of the art.
PubMed 文献 · RMD Open · 2017-11-14

本综述讨论在临床关节炎出现前的关节痛阶段识别高风险类风湿关节炎(RA)人群以实施预防治疗的可能性,总结了影像学和血清学标志物预测关节痛进展为关节炎的准确性,并指出多数发现尚未在独立研究中验证,未来研究应采用同质患者群体(如符合EULAR关节痛风险标准者)以提高可比性和结果验证。

要点

  • 关节痛阶段可能是RA预防治疗的窗口期,识别高风险人群是关键。
  • 影像学和血清学标志物预测关节痛进展为关节炎有前景,但多数未独立验证。
  • 未来研究应采用同质患者群体(如符合EULAR关节痛风险标准)以利结果验证。

核心结论

  • 关节痛阶段可能是RA预防治疗的窗口期,但预测关节痛进展为关节炎的标志物多数尚未在独立研究中验证。

研究设计与样本

  • 本文为综述,描述预测关节痛进展为关节炎的相关性及不同类型预测因子(包括影像学和血清学标志物)的准确性。

主要发现

  • 影像学和血清学标志物在预测关节痛进展为关节炎方面有前景,但研究人群异质且多数发现未在独立研究中验证。

关键数值与推荐

  • 未来观察性或预防性研究应采用同质患者群体(如符合欧洲抗风湿病联盟(EULAR)关节痛风险标准者)以提高研究间可比性和结果验证。

临床怎么用

  • 在关节痛阶段识别高风险RA人群可支持预防治疗的临床试验设计。
  • 临床预测工具的选择需考虑现有证据多来自异质人群且未经独立验证。

局限性

  • 研究人群异质,多数发现未在独立研究中验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Early initiation of treatment in patients with inflammatory arthritis at risk of persistence and/or erosive progression is important because it is associated with a reduced rate of progression of joint damage and functional disability. It has been proposed that a window of opportunity exists, during which disease processes are less matured and disease modification can be more effective. The phase of arthralgia preceding clinical arthritis is likely to be an important part of this window of opportunity, during which treatment might prevent progression to clinical arthritis. Several proof-of-concept trials in individuals with arthralgia are now evaluating this hypothesis. Central to such trials is the ability to identify groups at high risk of rheumatoid arthritis (RA) in whom preventive treatment can be tested. This review describes the relevance of adequate prediction making, as well as the accuracy of different types of predictors (including imaging and serological markers) with their value in predicting the progression of arthralgia to arthritis. Despite promising results, studies have been performed in heterogeneous patient populations and most findings have not been validated in independent studies. Future observational or preventive studies should be conducted with homogeneous patient groups (eg, patients fulfilling the European League Against Rheumatism criteria for arthralgia at risk of RA) in order to increase interstudy comparability and to allow result validation.

来源:RMD Open,查看原文。版权归原作者所有。

引用

  1. Boeters DM, Raza K, van der Helm-van Mil AHM, et al. Which patients presenting with arthralgia eventually develop rheumatoid arthritis? The current state of the art. RMD Open. 2017. PMID: 29177078. doi:10.1136/rmdopen-2017-000479

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。